Zoekresultaten - 22 results
Emergence of ST131 carrying carbapenemase genes, European Union/European Economic Area, August 2012 to May 2024.
(ST)131 and its single locus variants carrying carbapenemase genes from 17 European Union/European Economic Area countries revealed acquisition of 18 carbapenemase variants, mainly in ST131 clades A and C. ...
EU-HIP – Country visit report – Croatia
with HERA ’s IT Platform (EU- HIP)”. EU- HIP is a consortium of 15 European countries, coordinated by Statens Serum Institute (SSI), Denmark. The scope of the project is to support countries to enhance ...
Genomic epidemiology of emerging ESBL-producing Kentucky in Europe.
2013-2018 in eight European countries. Compared to other. Kentucky and non-typhoidal infections, reported to the European Surveillance System, these cases were more likely to be elderly and to present ...
Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017
healthcare-associated infections (HAI) and antimicrobial use in the European Union and European Economic Area (EU / EEA) from 2016 to 2017 included 310,755 patients from 1,209 acute care hospitals (ACH) in 28 countries ...
Antimicrobial use in European long-term care facilities: results from the third point prevalence survey of healthcare-associated infections and antimicrobial use, 2016 to 2017
2016–17. Twenty-four European Union/European Economic Area (EU / EEA) countries, the former Yugoslav Republic of Macedonia and Serbia participated in the third PPS in European LTCF s. Overall, 4.9% (95% ...
Antimicrobial use in European acute care hospitals: results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016 to 2017
hospitals. We included 1,209 hospitals and 310,755 patients in 28 of 31 European Union/European Economic Area (EU / EEA) countries. The weighted prevalence of antimicrobial use in the EU / EEA was 30.5% (95% ...
Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis
burden of infections caused by antibiotic-resistant bacteria of public health concern in countries of the EU and European Economic Area (EEA) in 2015, measured in number of cases, attributable deaths, and ...
Comparative genomics of quinolone-resistant and susceptible Campylobacter jejuni of poultry origin from major poultry producing European countries (GENCAMP)
quinolone resistance Abstract: A total of 502 Campylobacter jejuni isolates from poultry in 12 different European countries (10 of them the largest poultry production countries in Europe) were whole genome ...
Comparative genomics of quinolone‐resistant and susceptible Campylobacter jejuni of poultry origin from major poultry producing European countries (GENCAMP)
Publication Type: Peer reviewed scientific article Authors: Pimlapas Leekitcharoenphon; Cristina Garcia-Graells; N Botteldoorn; Katelijne Dierick; Isabelle Kempf; Satu Olkkola; Mirko Rossi; Suvi Nykäsenoja; Malorny, Burkhard; Kerstin Stingl; Antonio Batti ...
Epidemiology of Clostridium difficile infection in Belgium: Report 2016
Differences in surveillance methods of CDI reported in European countries make comparisons difficult. Health Topics: Résistance aux antimicrobiens (AMR) Antimicrobiële resistentie (AMR) Antimicrobial ...